Available from: Karim A, Mohammadi L, Osse EF, Aider M, Saqui-Salces M, Khalloufi S
Cancer Chemother Pharmacol 50(3):237-42, 2002
It is often prescribed to patients who have not had success with or experienced unwanted side effects from other antidepressants, such as selective serotonin reuptake inhibitors (SSRIs)
SGLT-2 inhibitors were superior to GLP-1RA in reducing the risk of HHF and the renal outcome (24% and 22% lower risk, respectively)
Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial
Targetting ferroptosis for blood cell-related diseases